HLTH USA: AI Configured on Clinical Guidelines to Find More Untreated Cachectic Cancer Patients

JAMIA Publication:The Potential and Pitfalls of using a LLM as a Clinical Assistant

Full Steam Ahead: How AI Can Transform the Genetics Journey in Precision Medicine

Pangaea Data Awarded Top Tier Co-Sell Partnership Status by Microsoft

WHITEPAPER: How can Pharma & Healthcare Collaborate in a Financially Sustainable & Scalable Manner?

GO BACK

Pangaea Selected to Present at the IHF World Hospital Congress

11:00AM - 12:00PM WEST, October 26th 2023, Lisbon Congress Centre, Portugal

Venue: Lisbon Congress Center, Lisbon, Portugal

Presentation Session: How innovations in early diagnostics and intervention solutions are being implemented into the NHS and improving the efficiency of cancer care in the UK

Learn how NHS clinicians applied Pangaea’s product to find and connect to 6x more undiagnosed and miscoded cachectic cancer patients compared to generic Natural Language Processing (NLP) and ICD approaches. This led to a 50% reduction in treatment costs (from £10,000 to £5,000 per patient), leading to a £1B savings annually in the context of 200,000 such patients in the UK, combined with improved resource allocation and patient outcomes. Whilst also benefitting pharmaceutical sponsors by connecting them to a 6x larger patient pool for their therapies and trials and 6x higher revenues, in a privacy-preserving manner.

Register to Meet Us

Presenter

Dr. Vibhor Gupta
Director & Founder
Pangaea Data